What was claimed
New KAIST study on cellular differentiation trajectories proves we can rewire cancer cells back to normal (digital twin/BENEIN approach) instead of killing them, fundamentally changing cancer treatment from destruction to redirection.
Our verdict
Needs cautionThe results suggest a potential therapeutic strategy, but they remain preclinical and do not establish a fundamental change in clinical cancer treatment. The study demonstrates proof-of-concept in colon cancer cells through in vitro and animal models, but this is not equivalent to clinical proof. Further clinical trials are required before efficacy in humans is established.